Similar articles

• Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis.

  Fowler KJ, Brown JJ, Narra VR. Fowler KJ, et al. Hepatology. 2011 Dec;54(6):2227-37. doi: 10.1002/hep.24679. Hepatology. 2011. PMID: 21932400 Review.
• Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.

  Kim HJ, Kim BS, Kim MJ, Kim SH, de Campos RO, Hernandes M, Semelka RC. Kim HJ, et al. J Magn Reson Imaging. 2013 Apr;37(4):903-8. doi: 10.1002/jmri.23874. Epub 2012 Oct 12. J Magn Reson Imaging. 2013. PMID: 23065959
• Focal nodular hyperplasia: typical and atypical MRI findings with emphasis on the use of contrast media.

  Marin D, Brancatelli G, Federle MP, Lagalla R, Catalano C, Passariello R, Midiri M, Vilgrain V. Marin D, et al. Clin Radiol. 2008 May;63(5):577-85. doi: 10.1016/j.crad.2007.06.011. Epub 2008 Jan 3. Clin Radiol. 2008. PMID: 18374723 Review.
• MRI features of inflammatory hepatocellular adenomas on hepatocyte phase imaging with liver-specific contrast agents.

  Thomeer MG, Willemssen FE, Biermann KK, El Addouli H, de Man RA, Ijzermans JN, Dwarkasing RS. Thomeer MG, et al. J Magn Reson Imaging. 2014 May;39(5):1259-64. doi: 10.1002/jmri.24281. Epub 2013 Jul 29. J Magn Reson Imaging. 2014. PMID: 23897798
• Gadoxetic acid-enhanced hepatobiliary phase MR imaging: cellular insight.

  Pastor CM. Pastor CM. Radiology. 2010 Nov;257(2):589. doi: 10.1148/radiol.101172. Radiology. 2010. PMID: 20959554 No abstract available.